Abeona Therapeutics Inc
(NAS:ABEO)
$
5.38
-0.11 (-2.01%)
Market Cap: 307.94 Mil
Enterprise Value: 179.55 Mil
PE Ratio: 0
PB Ratio: 2.40
GF Score: 30/100 Abeona Therapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 16, 2026 / 03:30PM GMT
Release Date Price:
$5.39
(-1.73%)
Vishwas Seshadri
Abeona Therapeutics Inc - President, Chief Executive Officer, Director
No, great, very thoughtful.
And I have some updates.
Unidentified Company Representative
I want to talk to you about -- we'll chat later about other stuff.
Vishwas Seshadri
Abeona Therapeutics Inc - President, Chief Executive Officer, Director
Yeah.
Unidentified Company Representative
Great. Thank you all for coming to the annual Morgan Stanley Healthcare Conference. My name is Rak Bion. I am the head of West Coast Healthcare Investment Banking for Morgan Stanley. I have the pleasure of hosting the Abiona Therapeutics Management Team today. We'll go through a few questions, but recognizing that this is the first time Abiona is at our conference, would love to maybe start with a round of introductions.
Vishwas Seshadri
Abeona Therapeutics Inc - President, Chief Executive Officer, Director
Thank you so much for having us, Rak. I'm Vishesh
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot